WordNet
- immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
PrepTutorEJDIC
- 牛痘種,痘苗(牛痘を起こすビールスで,天然痘予防のために人体に接種される) / (伝染病の病原菌から作った)ワクチン
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.
- Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J.SourceDuke University.
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.Clin Infect Dis.2012 Apr;54(7):922-8. Epub 2012 Jan 30.
- (See the Editorial Commentary by Li et al, on pages 929-30.) Background. Herpes zoster (HZ) adversely affects individuals aged 50-59, but vaccine efficacy has not been assessed in this population. This study was designed to determine the efficacy, safety, and tolerability of zoster vaccine for pre
- PMID 22291101
Japanese Journal
- 吉田 正己
- 東邦医学会雑誌 60(3), 154-158, 2013-03-00
- … RFLP-PCR was used to differentiate the wild strain from the vaccine strain of varicella-zoster virus. …
- NAID 120005306331
- 帯状疱疹後神経痛 (特集 発症原因別に見た神経障害性疼痛の最近の話題--予防・診断・治療)
Related Links
- References Citations National Advisory Committee on Immunization (NACI) (2006). VariZIG as the varicella zoster immune globulin for the prevention of varicella in at-risk patients. Canada Communicable Disease Report, 32(ACS-8): 1 ...
- Recent changes in the use and effects of the varicella-zoster vaccine in older adults and the varicella vaccine in children are the focus of two articles. ... Two articles focus on recent changes in the use and effects of the ...
Related Pictures
★リンクテーブル★
[★]
- 英
- varicella-zoster vaccine
- 関
- 水痘、帯状疱疹
[★]
水痘帯状疱疹
- 関
- VZ